Plant Protein: Pea, Soy, Rice & Blends — Independent Evidence vs Whey

Table of contents

• Evidence summary
• What plant protein is
• All forms and grades
• Protein quality: amino acids, leucine, DIAAS/PDCAAS
• How it works
• Benefits by claim
• What works and what does not
• Risks and all side effects
• All interactions
• Who should avoid plant protein
• Dosage and how to take
• Animal and in-vitro evidence excluded
• Independent funding and conflict notes
• Frequently asked questions
• Sources and funding notes

Evidence summary

Claim	Evidence	Source	Funding/conflict	Strength
Pea protein matches milk protein for acute muscle protein synthesis (MPS) when dosed high enough	Double-blind RCT, tracer methodology, 30 g pea vs. 30 g milk protein, identical MPS	Pinckaers et al. 2024, Eur J Nutr	TiFN (Dutch public-private consortium) — flagged as industry-adjacent	Strong
Soy matches whey for 12-week hypertrophy/strength when leucine-matched	61-person RCT, 19 g whey vs. 26 g soy, both 2 g leucine	Lynch et al. 2020, IJERPH	No industry funding disclosed	Strong
Pea protein (NUTRALYS) matches whey over 12 weeks of resistance training	161-person RCT, 25 g pea or whey twice daily	Babault et al. 2015, JISSN	Funded by Roquette, maker of NUTRALYS pea protein	Moderate (industry-funded)
Whey outperforms soy for 9-month lean-mass gain when not leucine-matched	RCT, whey vs. soy vs. carbohydrate, non-trained adults	Volek et al. 2013, J Am Coll Nutr	Solae LLC/DuPont (soy-protein company) involved	Moderate
Rice protein matches whey at a high (48 g) dose for body composition	8-week RCT, 48 g rice vs. 48 g whey	Joy et al. 2013, Nutr J	Authors linked to Increnovo LLC / Axiom Foods (Oryzatein maker)	Moderate (industry-funded)
Plant-based diets are not detrimental to muscular strength vs. omnivorous diets	Systematic review/meta-analysis of RCTs	López-Moreno et al. 2025, Sports Med Open	Academic; no industry funding	Strong
Soy/isoflavones do not lower testosterone or other male reproductive hormones	Two meta-analyses of placebo-controlled human trials	Hamilton-Reeves et al. 2010, Fertil Steril; Reed et al. 2021, Reprod Toxicol	Co-authored by Mark Messina, Soy Nutrition Institute (industry-funded)	Strong (direction consistent with independent trials within)
Soy has minimal effect on thyroid function in euthyroid, iodine-replete people	Review of 14 human trials	Messina & Redmond 2006, Thyroid	Messina authorship — soy-industry-linked	Moderate
Whey has higher leucine and EAA density per gram than any plant protein tested	Independent UPLC-MS/MS amino-acid analysis	Gorissen et al. 2018, Amino Acids	TI Food and Nutrition (Dutch public-private); low conflict risk (analytical chemistry)	Strong
Plant/organic protein powders carry higher lead and cadmium than conventional/animal powders	Independent testing, 165 top-selling powders, 70 brands	Clean Label Project 2025	Nonprofit tester funded by donations/certification fees	Moderate
ISSN protein dosing guidance (20–40 g per dose, 1.4–2.0 g/kg/day)	Position stand	Jäger et al. 2017, JISSN	ISSN has substantial supplement-industry sponsorship; several authors consult for supplement companies	Moderate

What plant protein is

"Plant protein" is an umbrella term covering isolates and concentrates extracted from legumes, cereals, and seeds — most commonly pea, soy, rice, hemp, and pumpkin seed — sold as single-source powders or, increasingly, as blends. Unlike whey (a single, standardized dairy by-product), plant proteins vary considerably by crop, extraction method, and processing, which is why quality and amino-acid completeness differ substantially between a pea isolate and a rice concentrate.

The commercial appeal is straightforward: plant proteins are vegan, dairy-free, and generally allergen-friendlier than whey for people with lactose intolerance or milk allergy (though soy and, increasingly, pea themselves carry allergen risk — see the safety section below). The scientific question this article focuses on is narrower and more useful: does plant protein actually build muscle as well as whey, and are the popular health worries (testosterone, thyroid, antinutrients) supported by human evidence?

All forms and grades

Form	Typical protein %	Amino-acid profile	Limiting amino acid	Notes
Pea protein isolate (e.g., NUTRALYS® by Roquette)	~80%	Good lysine content	Methionine (sulfur AAs)	Leading vegan sports-protein isolate; most-studied plant protein alongside soy for muscle outcomes
Soy protein isolate (SPI)	~90%	Complete EAA profile	Sulfur amino acids (methionine + cysteine)	Most-studied plant protein overall; also the most scrutinized for hormone/thyroid claims
Rice protein (brown rice / Oryzatein®)	~80% (isolate)	Moderate EAA density	Lysine	Needs a higher dose (~48 g) to match whey in trials; weaker alone at typical serving sizes
Hemp / pumpkin-seed protein	~50–70%	Lower EAA density overall	Lysine	Rarely used alone for muscle-building goals; mainly a blend component or fiber/fat co-source
Pea + rice blends	~75–80%	Complementary — pea's lysine offsets rice's deficit; rice's methionine offsets pea's deficit	None (complementary)	Blending 40–90% pea with rice raises PDCAAS to ~1.00, matching whey and soy on paper

Protein quality: amino acids, leucine, DIAAS/PDCAAS

The most reliable, independently generated amino-acid dataset comes from the van Loon lab's UPLC-MS/MS analysis, which measured leucine and total essential amino acid (EAA) content directly rather than relying on older tabulated averages (Gorissen et al. 2018, Amino Acids, PMC; funded by TI Food and Nutrition, a Dutch public-private consortium — partially industry-adjacent, but the measurements are analytical chemistry with low conflict risk).

Protein	Leucine (% of protein)	ΣEAA (% of protein)	Limiting amino acid
Whey	~11.0%	~43%	Histidine
Milk	7.0% (of AA)	39%	—
Soy	~8%	19.9% (of raw)	Sulfur AAs (Met+Cys)
Pea	7.2%	~30% (of protein)	Methionine
Brown rice	5.8%	22.1% (of raw)	Lysine
Hemp	5.1%	11.6% (of raw)	Lysine
Corn (for reference)	13.5% (high but lysine-poor)	21%	Lysine

Every common plant protein has lower leucine and EAA density than whey, and each carries its own specific limiting amino acid — the biological basis for the "plant protein is less anabolic per gram" argument (Gorissen et al. 2018). The practical fix is either a larger dose to clear the leucine threshold, or a complementary blend: to match the 2.7 g leucine found in 25 g whey, a person needs roughly 38 g pea, 40 g soy, or 37 g brown-rice protein (Gorissen et al. 2018).

Protein quality scores tell a similar story. Using digestibility-based scoring, plant proteins generally trail whey and soy:

Protein	PDCAAS	DIAAS	Limiting AA
Whey	0.97–1.00	~0.90	Histidine
Soy	0.99–1.00	~0.92	Sulfur AAs
Pea	0.83–0.91	~0.66	Sulfur AAs, Trp
Rice	0.53–0.64	~0.52	Lysine, Thr
Wheat (for reference)	0.45–0.54	~0.39	Lys, Leu, Thr

This table is compiled by Hertzler et al. 2020, Nutrients, PMC — ⚠ funded by Abbott Nutrition (industry); flagged. The values themselves compile third-party published figures, but the funding source warrants caution when reading the framing around them. A separate pig ileal-digestibility study — ⚠ IN-VIVO PIG MODEL, flagged, the FAO/OECD-standard proxy for human ileal digestion because human ileal-cannulation data are scarce — similarly ranked whey and soy isolate above pea concentrate (Mathai, Liu & Stein 2017, Br J Nutr, PubMed; University of Illinois). Encouragingly, pea+rice blends (40–90% pea) reach a PDCAAS of ~1.00, essentially matching whey and soy on this metric by pairing pea's higher lysine with rice's adequate methionine (Hertzler et al. 2020).

How it works

Muscle protein synthesis (MPS) is triggered mainly by circulating leucine crossing a threshold that activates the mTOR signaling pathway; total EAA availability then supplies the building blocks to sustain the response. This is why leucine density, not just total protein grams, determines how quickly a given serving stimulates MPS. Because pea, soy, rice, and hemp protein all deliver less leucine per gram than whey (Gorissen et al. 2018), a "gram-for-gram" comparison unfairly disadvantages plant protein — the fairer comparison is dose-matched or leucine-matched, which is exactly what the strongest human trials below do.

Digestibility also matters: DIAAS and PDCAAS scores estimate how much of a protein's amino acids actually reach the bloodstream after gut digestion. These scores rely partly on pig ileal-cannulation models (flagged as an animal/non-human model) because equivalent human ileal data are rare (Mathai et al. 2017). These digestibility scores are a reasonable proxy for how efficiently a protein is absorbed, but they are not themselves proof of a human muscle-building effect — that requires the tracer and hypertrophy trials described next.

Benefits by claim

Muscle protein synthesis (MPS) — acute

The most methodologically rigorous and most independent evidence here is a double-blind tracer RCT: 30 g pea protein produced myofibrillar MPS identical to 30 g milk protein (both 0.053%/h, p=0.96) in healthy young men, even though milk raised plasma EAAs and leucine about 25% more — the pea dose was simply large enough to clear the anabolic threshold (Pinckaers et al. 2024, Eur J Nutr, PMC; van Loon lab, Maastricht; funded by TiFN, a Dutch public-private consortium with some industry members — flagged, though the tracer methodology and a null-for-difference result are hard to bias toward the plant protein). This is the single strongest piece of evidence that dose-matched plant protein is not inherently inferior for triggering MPS.

Hypertrophy and strength — 12 weeks and longer

Three head-to-head resistance-training trials define this claim:

• Soy vs. whey, leucine-matched (independent): 61 untrained adults given 19 g whey (2 g leucine) or 26 g soy (2 g leucine) for 12 weeks of resistance training gained equivalent lean mass and strength, with no significant between-group difference (Lynch et al. 2020, IJERPH, PMC; Point Loma / Arizona State; academic, no industry funding disclosed). This is the cleanest independent evidence for soy–whey parity when leucine is equalized.
• Pea vs. whey (NUTRALYS): 161 men given 25 g pea or whey twice daily for 12 weeks saw biceps thickness increase in all groups; pea beat placebo and did not differ from whey (Babault et al. 2015, JISSN, Taylor & Francis; ⚠ funded by Roquette, maker of NUTRALYS pea protein — industry-conflicted, though it usefully corroborates the pea-equals-whey finding from independent sources).
• Whey vs. soy, not leucine-matched (9 months): In non-trained adults, whey produced greater lean-mass gains (3.3 kg) than soy (1.8 kg) or carbohydrate (2.3 kg), with fasting leucine correlating with lean-mass response (Volek et al. 2013, J Am Coll Nutr, PubMed; University of Connecticut; ⚠ supplements/funding involved Solae LLC/DuPont, a soy-protein company — notably, a soy-linked sponsor's trial still favored whey, which slightly reduces concern about pro-whey bias, but the doses were not leucine-matched, which likely explains whey's advantage).
• Rice vs. whey, high dose: 48 g rice protein isolate vs. 48 g whey post-training produced comparable gains in lean mass, strength, and body composition over 8 weeks (Joy et al. 2013, Nutr J, PMC; ⚠ authors linked to Increnovo LLC; product ties to Axiom Foods' Oryzatein rice protein — industry-conflicted). Note the unusually high 48 g dose, which offsets rice's low lysine content and low per-gram leucine.

Honest reading: acute-MPS and long-term hypertrophy trials converge — pea and soy match whey for muscle building when dose (and leucine) are adequate. Whey retains a per-gram advantage (higher leucine density, faster absorption kinetics), which matters most at small serving sizes or in anabolic-resistant older adults.

Strength across broader plant-based diets

Beyond single-ingredient trials, a 2025 systematic review and meta-analysis of RCTs comparing plant-based vs. omnivorous diets concluded that plant-based diets are not detrimental to muscular strength (López-Moreno et al. 2025, Sports Med Open, PMC; Spanish/Latin-American universities; academic, no industry funding). This independent, dietary-pattern-level evidence supports the ingredient-level trials above.

Glycemia, satiety, sarcopenia

Dedicated human trials isolating plant protein (as opposed to whole plant-based diets) for glycemic control, satiety, or sarcopenia specifically are far sparser than the whey literature. The muscle-building trials above are the strongest and most direct evidence base for plant protein; no comparably rigorous independent human RCTs isolating pea, soy, or rice protein powder for glycemia or satiety endpoints were identified in this review. This is a genuine evidence gap, not a negative finding — it should not be read as "plant protein has no effect," only that specific supplement-grade trials are lacking.

What works and what does not

Claim	Verdict	Basis
Pea or soy protein can build muscle as well as whey	Works — at adequate dose/leucine	Pinckaers 2024; Lynch 2020
A standard small scoop (~20 g) of pea/soy/rice protein matches a 25 g whey scoop for MPS	Does not work as well — under-doses leucine	Gorissen 2018 (need ~38g pea / 40g soy / 37g rice to match 25g whey's leucine)
Rice protein alone at typical (20–25 g) doses matches whey	Does not work well — needs ~48 g dose	Joy 2013
Pea + rice blends solve the amino-acid gap	Works on paper (PDCAAS ~1.00)	Hertzler 2020 (Abbott-funded, flagged)
Soy lowers testosterone or feminizes men	Does not hold up — refuted by human meta-analyses	Hamilton-Reeves 2010; Reed 2021 (Messina/SNI-authored, flagged)
Soy meaningfully disrupts thyroid function in healthy, iodine-replete people	Does not hold up — minimal effect	Messina & Redmond 2006 (flagged)
Processed plant isolates carry meaningful antinutrient (phytate/lectin) harm	Does not hold up for isolates — largely in-vitro/animal concern, minimal in processed products	See Animal/in-vitro exclusions section
Plant/organic protein powders are free of heavy-metal risk	Does not hold up — plant/organic powders test highest for lead	Clean Label Project 2025

Risks and all side effects

Risk	What the evidence shows	Severity/frequency	Source
Antinutrients (phytates, lectins)	Reduce mineral absorption in vitro/animal models; modern isolates are processed to remove most antinutrients, and independent human relevance for well-processed isolates is minimal	Low — theoretical for processed isolates	In-vitro/animal data only; excluded as proof of human harm (see exclusions section)
Soy allergy	Soy is one of the major recognized food allergens	Can be serious in sensitized individuals	Established clinical allergen status
Pea allergy / peanut cross-reactivity	Pea allergy is rising in prevalence and can cross-react with peanut in sensitized people	Uncommon but genuine clinical concern	Documented clinical allergy literature
Heavy metals (lead, cadmium, arsenic, mercury)	Independent testing of 165 top-selling powders (70 brands, 35,862 data points) found 47% exceeded at least one federal/state safety threshold; plant-based and organic powders carried the highest lead, averaging ~3× the lead of non-organic powders	Population-level contamination signal; magnitude varies by brand	Clean Label Project 2025 (nonprofit tester; sells certification, so exact rankings should be treated cautiously even as the population finding is credible)
Protein/nitrogen spiking	Plant proteins are as vulnerable as whey to nitrogen-based testing being gamed with cheap free amino acids or non-protein nitrogen, inflating apparent protein content without delivering usable EAAs	Product-specific; undisclosed on most labels	Nutritional Outlook / US Pharmacopeia
Thyroid medication absorption (soy specifically)	Soy can reduce absorption of levothyroxine; this is a pharmacokinetic interaction, separate from any direct thyroid-hormone-disrupting effect	Manageable by timing separation	Messina & Redmond 2006 (flagged, Messina authorship)
GI tolerability (fiber-heavy blends)	Pea and hemp proteins can carry more residual fiber than whey or SPI, occasionally causing bloating in sensitive individuals; not systematically quantified in RCTs referenced here	Mild, individual-dependent	General product-composition observation; not a specific cited RCT

All interactions

Interacting substance/medication	Mechanism	Direction/severity	Evidence quality
Levothyroxine (thyroid hormone replacement)	Soy protein/isoflavones can bind or interfere with intestinal absorption of levothyroxine	Reduced drug absorption — separate from medication timing; caution, not avoidance	Human trial review (Messina & Redmond 2006, flagged for Messina/soy-industry authorship); practical fix is to separate soy intake from dosing by several hours
MAOIs / tyramine-sensitive regimens	Not specifically documented for plant protein isolates in the research reviewed; theoretical only for fermented/processed plant products	No established interaction for standard pea/soy/rice isolates	Data gap — no dedicated human interaction studies identified
Anticoagulants (e.g., warfarin) and soy's vitamin K content	Whole soybeans/soy foods contain some vitamin K and isoflavones with theoretical mild effects on clotting; purified soy protein isolate has minimal vitamin K	Unclear for isolate powders specifically	Data gap — no dedicated human RCTs on soy protein isolate and anticoagulant interaction identified in the source research
Other medications/supplements generally	No dedicated independent human interaction studies for pea, rice, or hemp protein isolates were identified in the underlying research	Data gap	This is a real gap in the literature, not evidence of safety — flagged as a limitation rather than an assurance

Overall, drug-interaction research specific to plant protein powders (as opposed to whole soy foods) is thin. The one well-documented interaction — soy and levothyroxine absorption — is worth knowing for anyone on thyroid medication; beyond that, this is a genuine data gap that should not be interpreted as proof of "no interactions."

Who should avoid plant protein

• People with a diagnosed soy allergy should avoid soy protein isolate specifically (pea, rice, or hemp are reasonable alternatives).
• People with pea allergy or peanut allergy with legume cross-reactivity should be cautious with pea protein isolate and discuss with an allergist before use.
• People on levothyroxine or other thyroid medication should separate soy protein intake from their medication dose by several hours to avoid absorption interference (Messina & Redmond 2006).
• People seeking to minimize heavy-metal exposure should prioritize brands with independent third-party contaminant testing (e.g., Informed Protein, NSF Certified for Sport), given that plant/organic powders test highest for lead in independent surveys (Clean Label Project 2025).
• People relying on a single low-dose scoop (15–20 g) of pea, soy, or rice protein for maximal muscle-building signal should reconsider — the leucine threshold is not reliably cleared at that dose; either increase serving size or choose a complementary pea+rice blend (Gorissen et al. 2018).
• People with kidney or metabolic conditions requiring individualized dietary protein limits should consult a clinician regardless of protein source, as this article does not address disease-specific dosing.

Dosage and how to take

Protein type	Dose to match ~2.7g leucine (whey-equivalent trigger)	Dose used in successful hypertrophy trials	Timing notes
Pea isolate	~38 g	25 g twice daily (Babault 2015, Roquette-funded); 30 g matched milk protein MPS in Pinckaers 2024	Post-exercise or spread across meals; larger doses compensate for lower leucine density
Soy isolate	~40 g	26 g (leucine-matched to 19 g whey) in Lynch 2020	Leucine-matching (rather than gram-matching) achieved parity with whey in the strongest independent trial
Rice protein	~37 g	48 g matched whey in Joy 2013 (Axiom/Increnovo-funded)	Higher doses needed given rice's low lysine and leucine density; rarely effective alone at <30 g
Pea+rice blend	Lower than single sources due to complementary amino acids (PDCAAS ~1.00)	No dedicated blend hypertrophy RCT identified; extrapolated from quality scores	A practical way to approach whey-equivalent quality without a very large single-source dose
General (ISSN guidance)	20–40 g per dose to maximize MPS; 1.4–2.0 g/kg/day total protein for active individuals (up to ~2.2 g/kg/day in a caloric deficit for muscle retention)	—	Jäger et al. 2017, ISSN Position Stand — flagged for substantial supplement-industry sponsorship of the society and several authors

Animal and in-vitro evidence excluded

Per Pure City Research methodology, the following animal and non-human evidence was encountered during research but excluded from all efficacy and safety conclusions above. It is listed here only for transparency:

• Aged-mouse (murine) model of pea+soy+leucine-fortified blends and MPS — excluded as an animal study; noted only as a hypothesis-generating signal that leucine fortification of plant blends may raise MPS, which requires confirmation in human trials.
• Pig ileal-digestibility model (Mathai, Liu & Stein 2017) — the FAO/OECD reference method for DIAAS, and pigs closely mirror human ileal digestion, but this remains a non-human model. Values are reported and flagged, not treated as direct human digestibility proof (PubMed).
• Soy-thyroid in-vitro/animal signals — theoretical thyroid-goitrogen concerns from cell-based or animal studies are excluded as proof of human harm; human trials show only minimal effect in euthyroid, iodine-replete people (Messina & Redmond 2006).
• Antinutrient (phytate/lectin) harm claims — based on in-vitro or animal data; excluded as proof of harm from modern, processed plant protein isolates, where independent human relevance is minimal.

IN-VITRO / non-human evidence used: Only for digestibility/protein-quality scoring (DIAAS/PDCAAS derived from the pig ileal model), always explicitly flagged, because human ileal-cannulation DIAAS data for most plant proteins are scarce. This is not used to claim any human muscle, satiety, hormonal, or clinical effect.

Independent funding and conflict notes

Study	Design	Funding/conflict	Result
Pinckaers 2024 (pea vs. milk MPS)	Tracer RCT	TiFN (Dutch public-private consortium) — flagged as industry-adjacent	Pea = milk for MPS
Lynch 2020 (soy vs. whey)	12-week RCT, leucine-matched	No industry funding disclosed	Soy = whey
Babault 2015 (NUTRALYS pea vs. whey)	12-week RCT	Roquette (pea protein maker) — industry-funded	Pea = whey
Volek 2013 (whey vs. soy)	9-month RCT	Solae/DuPont (soy company) involved	Whey > soy (not leucine-matched)
Joy 2013 (rice vs. whey)	8-week RCT	Increnovo LLC / Axiom Foods (Oryzatein rice protein) — industry-conflicted	Rice = whey at 48 g
Hamilton-Reeves 2010; Reed 2021	Hormone meta-analyses	Mark Messina / Soy Nutrition Institute (industry-funded); co-authors sit on SNI's advisory board	No testosterone effect
Messina & Redmond 2006 (soy/thyroid)	Review of 14 human trials	Messina authorship — soy-industry-linked	Minimal thyroid effect in euthyroid people; reduces levothyroxine absorption
López-Moreno 2025	Strength meta-analysis	No industry funding disclosed	Plant diets not detrimental to strength
Hertzler 2020 (DIAAS/PDCAAS table)	Narrative/compilation review	Abbott Nutrition — industry-funded	Compiles published quality scores; pea+rice blends reach PDCAAS ~1.00
Mathai/Stein 2017 (DIAAS)	Pig ileal-digestibility model	University of Illinois; no industry funding disclosed in abstract	Whey and soy isolate outrank pea concentrate; pig model, flagged
Gorissen 2018 (amino-acid analysis)	Independent UPLC-MS/MS analytical chemistry	TI Food and Nutrition (Dutch public-private consortium)	Whey highest leucine/EAA; plant proteins all lower, each with a specific limiting AA
Clean Label Project 2025	Independent contaminant testing	Nonprofit funded by donations/certification fees — sells certification, so exact rankings warrant some caution	Plant/organic powders highest in lead; 47% of tested powders exceeded a safety threshold
Jäger 2017 (ISSN Position Stand)	Position stand	ISSN has substantial supplement-industry sponsorship; several authors consult for supplement companies	Dosing guidance well-supported by independent tracer work despite society's industry ties

Frequently asked questions

Is plant protein as good as whey for building muscle?

When dose and leucine content are matched, yes — independent tracer and hypertrophy trials show pea and soy protein produce muscle protein synthesis and strength/lean-mass gains statistically indistinguishable from whey (Pinckaers et al. 2024; Lynch et al. 2020). The catch is the word "matched" — a typical small scoop of pea or soy protein delivers less leucine than the same-sized scoop of whey, so plant-protein users often need a somewhat larger serving (Gorissen et al. 2018).

Does soy protein lower testosterone in men?

No — two human meta-analyses of placebo-controlled trials found no significant effect of soy or isoflavones on total testosterone, free testosterone, SHBG, or free androgen index (Hamilton-Reeves et al. 2010; Reed et al. 2021). Readers should know both analyses are co-authored by Mark Messina, executive director of the industry-funded Soy Nutrition Institute — a conflict worth disclosing, though the no-effect finding is also consistent with independent trials included within those same meta-analyses.

Does soy protein hurt thyroid function?

In euthyroid, iodine-replete people, a review of 14 human trials found little evidence of meaningful thyroid harm (Messina & Redmond 2006 — flagged for soy-industry-linked authorship). The one genuine, separate concern is pharmacokinetic: soy can reduce absorption of levothyroxine medication, so people on thyroid replacement therapy should separate soy intake from their dose by a few hours.

Which plant protein has the best amino-acid profile?

Soy isolate has the most complete amino-acid profile among common plant proteins and the highest DIAAS/PDCAAS scores (~0.92 DIAAS), limited mainly by sulfur amino acids. Pea is close behind but limited by methionine and lower overall EAA density; rice trails both, limited by lysine (Gorissen et al. 2018; Hertzler et al. 2020, Abbott-funded, flagged). Pea+rice blends can reach a PDCAAS of ~1.00 by combining their complementary amino acids.

Are heavy metals a real concern in plant protein powders?

Yes — this is the most consequential independent safety finding for plant protein. Testing of 165 top-selling powders found plant-based and "organic" powders carried roughly 3× the lead of non-organic/animal-based powders, and 47% of all tested products exceeded at least one federal or state safety threshold (Clean Label Project 2025). Choosing brands with independent third-party contaminant testing meaningfully reduces this risk.

Do antinutrients in pea or soy protein block mineral absorption?

The theoretical concern is real in raw, unprocessed legumes and rests mainly on in-vitro and animal data, which this article excludes as proof of human harm. Modern protein isolates are processed specifically to remove most phytates and lectins, and independent human relevance for well-processed isolates is considered minimal.

Sources and funding notes

• Gorissen et al. 2018, Amino Acids, PMC — independent UPLC-MS/MS amino-acid analysis; funded by TI Food and Nutrition (Dutch public-private consortium).
• Hertzler et al. 2020, Nutrients, PMC — DIAAS/PDCAAS compilation; funded by Abbott Nutrition (industry-funded, flagged).
• Mathai, Liu & Stein 2017, Br J Nutr, PubMed — pig ileal-digestibility DIAAS model (flagged as animal/non-human model); University of Illinois.
• Pinckaers et al. 2024, Eur J Nutr, PMC — pea vs. milk MPS tracer RCT; van Loon lab, Maastricht; funded by TiFN (public-private, flagged).
• Lynch et al. 2020, IJERPH, PMC — soy vs. whey leucine-matched 12-week RCT; no industry funding disclosed.
• Babault et al. 2015, JISSN, Taylor & Francis — pea vs. whey 12-week RCT; funded by Roquette (NUTRALYS maker, flagged).
• Volek et al. 2013, J Am Coll Nutr, PubMed — whey vs. soy 9-month RCT; Solae/DuPont involvement (flagged).
• Joy et al. 2013, Nutr J, PMC — rice vs. whey 8-week RCT; Increnovo/Axiom Foods conflict (flagged).
• López-Moreno et al. 2025, Sports Med Open, PMC — plant-based diets and strength meta-analysis; no industry funding disclosed.
• Hamilton-Reeves et al. 2010, Fertil Steril, PubMed — soy/testosterone meta-analysis; Messina/Soy Nutrition Institute authorship (flagged).
• Reed et al. 2021, Reprod Toxicol, PubMed — updated soy/testosterone meta-analysis; Messina/Soy Nutrition Institute authorship (flagged).
• Messina & Redmond 2006, Thyroid, PubMed — soy and thyroid function review; Messina authorship (flagged).
• Clean Label Project 2025 Protein Study — independent heavy-metal contaminant testing; nonprofit, funded by donations/certification fees.
• Nutritional Outlook / US Pharmacopeia — protein/nitrogen spiking overview.
• Jäger et al. 2017, JISSN ISSN Position Stand, PubMed — protein dosing guidance; ISSN has substantial supplement-industry sponsorship (flagged).

Last reviewed: July 4, 2026.